ClinicalTrials.gg
RecruitingNCT07284771Updated Nov 20, 2026

MUSCLE-ML: Multimodal Integration of Muscle Strength, Structure by Machine Learning for Precision Rehabilitation After ACL Injury

An observational study in Machine Learning and Anterior Cruciate Ligament Reconstruction (ACLR), sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Chinese University of Hong Kong · Observational

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 20, 2026Now RecruitingFirst site in Hong Kong+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
182
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to use machine learning (ML) to predict functional recovery by integrating muscle-related factors and other relevant parameters for identification of non-responders to conventional rehabilitation. The main questions it aims to answer are:

Do deficit clusters lead to poorer functional recovery compared to non-deficit clusters? Does an ML-derived composite score that integrates quadriceps/hamstring strength and size outperform isolated metrics in predicting RTP success?

Researchers will compare deficit clusters against non-deficit clusters to determine if deficit clusters lead to poorer functional recovery.

Participants will:

Return for 5 follow-up timepoints in total for PRO and functional assessments including pre-operation, 1-, 3-, 6- and 12-months post-operation.

02

Conditions studied

  • Machine Learning
  • Anterior Cruciate Ligament Reconstruction (ACLR)
03

In context

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,458 studies on the registry; 478 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

All the ACLR patients will be recruited at the Orthopaedics Outpatient Clinic at Prince of Wales Hospital and Intelligent Orthopaedics and Sports Medicine Centre(IOSM).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unilateral ACL injury and plan for ACLR
  • Commit the post-operation physiotherapy in Prince of Wales Hospital

Exclusion criteria

Exclusion Criteria:

  • Preoperative radiographic signs of arthritis
  • Patient non-compliance to the rehabilitation program
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
182 participants (estimated)
Patient registry
No

Groups and cohorts

  • Deficit group

    Other: No Intervention: Observational Cohort

  • Healthy group

    Other: No Intervention: Observational Cohort

Interventions

  • OtherNo Intervention: Observational Cohort

    no intervention

    Also known as: No intervention

06

What researchers measure

Primary outcomes

  1. International Knee Documentation Committee score

    Consisted of 10 questions on symptoms and activity ranging from 0 to 100, where 100 implies perfect knee function

    Time frame: 6- and 12-months post-operation

07

Study locations

1 of 1 sites recruiting
  • Prince of Wales Hospital, Intelligent Orthopaedics and Sports Medicine Centre
    Hong Kong, Hong Kong
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Sep 2026 (actual). Primary completion is estimated for Mar 2028, 18 months after the start.

Start moved once since we started tracking on Sep 25, 2026: Apr 2026 → Sep 2026, on Nov 20, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2025
First posted
Dec 16, 2025
StartActual
Sep 18, 2026was Apr 2026
Primary completionEst.
Mar 31, 2028
CompletionEst.
Aug 31, 2028
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 20, 2026
Sites
1 site added — first site in Hong Kong
Show site
  • Prince of Wales Hospital, Intelligent Orthopaedics and Sports Medicine Centre · Hong Kong, Hong Kong
Nov 20, 2026
Start date
Apr 1, 2026→Sep 18, 2026 (actual)
Nov 20, 2026
Eligibility
Minimum age none→18 Years
Nov 20, 2026
Interventions
Arms added: Healthy group
Nov 20, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionInternational Knee Documentation Committee score: how it is measured was reworded
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Hong Kong
    Show site
    • Prince of Wales Hospital, Intelligent Orthopaedics and Sports Medicine Centre · Hong Kong, Hong Kong
    Start date Apr 1, 2026→Sep 18, 2026 (now actual)
    Eligibility Minimum age none→18 Years
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionInternational Knee Documentation Committee score: how it is measured was reworded
    Interventions Arms added: Healthy group
    + 2 other changes: verification date and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07284771
Responsible party
Patrick Shu-Hang YUNG (Professor and Chairman, Department of Orthopaedics & Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Chinese University of Hong Kong) — Principal investigator
First posted
Dec 16, 2025
Start date
Sep 18, 2026
Primary completion
Mar 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Nov 20, 2026

Study contacts

muriel XIAO
Contact
lingqingxiao@cuhk.edu.hk
(852)35053311
Shu Hang YUNG
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion